EE03074B1 - Rekombinantsed eukarüootsed rakud, nende saamiseks vajalikud DNA järjestused, meetod eukarüootsete rakkude konstrueerimiseks ja sekreteeritavate valkude ning biomassi tootmismeetod - Google Patents
Rekombinantsed eukarüootsed rakud, nende saamiseks vajalikud DNA järjestused, meetod eukarüootsete rakkude konstrueerimiseks ja sekreteeritavate valkude ning biomassi tootmismeetodInfo
- Publication number
- EE03074B1 EE03074B1 EE9400433A EE9400433A EE03074B1 EE 03074 B1 EE03074 B1 EE 03074B1 EE 9400433 A EE9400433 A EE 9400433A EE 9400433 A EE9400433 A EE 9400433A EE 03074 B1 EE03074 B1 EE 03074B1
- Authority
- EE
- Estonia
- Prior art keywords
- eukaryotic cells
- production
- secreted proteins
- biomass
- dna sequences
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Seasonings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI924494A FI924494A0 (fi) | 1992-10-06 | 1992-10-06 | Oekad produktion av avsoendrarde proteiner i eukaryotiska rekombinantceller |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE03074B1 true EE03074B1 (et) | 1998-02-16 |
Family
ID=8535988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9400433A EE03074B1 (et) | 1992-10-06 | 1994-11-22 | Rekombinantsed eukarüootsed rakud, nende saamiseks vajalikud DNA järjestused, meetod eukarüootsete rakkude konstrueerimiseks ja sekreteeritavate valkude ning biomassi tootmismeetod |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5789193A (da) |
| EP (1) | EP0665890B1 (da) |
| JP (1) | JP3638599B2 (da) |
| AT (1) | ATE254663T1 (da) |
| AU (1) | AU678402B2 (da) |
| CA (1) | CA2146240C (da) |
| DE (1) | DE69333304T2 (da) |
| DK (1) | DK0665890T3 (da) |
| EE (1) | EE03074B1 (da) |
| ES (1) | ES2211870T3 (da) |
| FI (2) | FI924494A0 (da) |
| NO (1) | NO319132B1 (da) |
| NZ (1) | NZ256425A (da) |
| WO (1) | WO1994008024A1 (da) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3020273A1 (en) | 2014-11-17 | 2016-05-18 | Competence Centre on Health Technologies | A method of producing biotechnological drugs using transgenic bovine animals |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922561A (en) * | 1994-10-03 | 1999-07-13 | Novo Nordisk Biotech, Inc. | Genes encoding signal recognition particle of Aspergillus niger |
| DE19920712A1 (de) * | 1999-05-05 | 2000-11-09 | Rhein Biotech Proz & Prod Gmbh | Verfahren zum Herstellen eines rekombinanten Proteines |
| US7678570B2 (en) | 2004-03-01 | 2010-03-16 | Kitakyushu Foundation For The Advancement Of Industry, Science And Technology | Human cell strains for protein production, provided by selecting strains with high intracellular protein and mutating with carcinogens |
| US20090247609A1 (en) * | 2007-12-20 | 2009-10-01 | Hitto Kaufmann | Sm-protein based secretion engineering |
| EP3784791A1 (en) | 2018-04-23 | 2021-03-03 | DuPont Nutrition Biosciences ApS | Increasing export of 2' fucosyllactose from microbial cells through the expression of a heterologous nucleic acid |
| EP4194560A1 (en) | 2021-12-08 | 2023-06-14 | European Molecular Biology Laboratory | Improved production of secreted proteins in fungal cells |
| CN114717124B (zh) * | 2022-04-19 | 2024-07-12 | 天津科技大学 | 一株高产麦角甾醇的酿酒酵母工程菌株、构建方法及应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0284044B1 (en) * | 1987-03-23 | 1994-03-23 | Zymogenetics, Inc. | High level expression in yeast |
-
1992
- 1992-10-06 FI FI924494A patent/FI924494A0/fi not_active Application Discontinuation
-
1993
- 1993-10-06 WO PCT/FI1993/000402 patent/WO1994008024A1/en active IP Right Grant
- 1993-10-06 DK DK93921939T patent/DK0665890T3/da active
- 1993-10-06 AU AU51127/93A patent/AU678402B2/en not_active Expired
- 1993-10-06 EP EP93921939A patent/EP0665890B1/en not_active Expired - Lifetime
- 1993-10-06 AT AT93921939T patent/ATE254663T1/de active
- 1993-10-06 DE DE69333304T patent/DE69333304T2/de not_active Expired - Lifetime
- 1993-10-06 ES ES93921939T patent/ES2211870T3/es not_active Expired - Lifetime
- 1993-10-06 CA CA002146240A patent/CA2146240C/en not_active Expired - Lifetime
- 1993-10-06 NZ NZ256425A patent/NZ256425A/en not_active IP Right Cessation
- 1993-10-06 JP JP50875394A patent/JP3638599B2/ja not_active Expired - Lifetime
- 1993-10-06 US US08/411,706 patent/US5789193A/en not_active Expired - Lifetime
-
1994
- 1994-11-22 EE EE9400433A patent/EE03074B1/xx unknown
-
1995
- 1995-04-05 FI FI951633A patent/FI114482B/fi not_active IP Right Cessation
- 1995-04-05 NO NO19951315A patent/NO319132B1/no not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3020273A1 (en) | 2014-11-17 | 2016-05-18 | Competence Centre on Health Technologies | A method of producing biotechnological drugs using transgenic bovine animals |
Also Published As
| Publication number | Publication date |
|---|---|
| US5789193A (en) | 1998-08-04 |
| DE69333304T2 (de) | 2004-08-26 |
| NO951315L (no) | 1995-06-06 |
| EP0665890B1 (en) | 2003-11-19 |
| NO319132B1 (no) | 2005-06-20 |
| JP3638599B2 (ja) | 2005-04-13 |
| ES2211870T3 (es) | 2004-07-16 |
| FI951633A0 (fi) | 1995-04-05 |
| EP0665890A1 (en) | 1995-08-09 |
| FI114482B (fi) | 2004-10-29 |
| FI924494A0 (fi) | 1992-10-06 |
| ATE254663T1 (de) | 2003-12-15 |
| JPH08501695A (ja) | 1996-02-27 |
| WO1994008024A1 (en) | 1994-04-14 |
| FI951633A (fi) | 1995-04-05 |
| CA2146240C (en) | 2007-05-01 |
| DK0665890T3 (da) | 2004-03-08 |
| NZ256425A (en) | 1996-08-27 |
| DE69333304D1 (de) | 2003-12-24 |
| AU678402B2 (en) | 1997-05-29 |
| AU5112793A (en) | 1994-04-26 |
| CA2146240A1 (en) | 1994-04-14 |
| NO951315D0 (no) | 1995-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1020528A3 (en) | Method for producing secreted proteins | |
| WO2002014358A3 (en) | Novel secreted proteins and their uses | |
| BR9914278A (pt) | Cepa de chrysosporium mutante, construção de ácido nucléico, cepa microbiana recombinante, métodos para produzir um polipeptìdeo de interesse, e para produzir uma cepa de chrysosporium mutante, e, xilanase de chrysosporium da famìlia de xilanases f, | |
| DE59608743D1 (de) | Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte-fermentation | |
| MX428A (es) | Region regulatoria para expresion de gen heterologa en levadura. | |
| DK1129190T3 (da) | Human TSLP DNA og polypeptider | |
| DK1090129T4 (da) | Overekspression af phytase-gener i gærsystemer | |
| DE3585953D1 (de) | Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine. | |
| WO1995006735A3 (en) | Nucleotide sequences for novel protein tyrosine phosphatases | |
| ATE309353T1 (de) | Verfahren zur herstellung von rekombinanten peptiden | |
| PT1025245E (pt) | Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes | |
| EE03074B1 (et) | Rekombinantsed eukarüootsed rakud, nende saamiseks vajalikud DNA järjestused, meetod eukarüootsete rakkude konstrueerimiseks ja sekreteeritavate valkude ning biomassi tootmismeetod | |
| WO2001032882A3 (en) | Nucleic acids and proteins from group b streptococcus | |
| DE3785798D1 (de) | Verfahren zur gentechnologischengewinnung von proteinen unter verwendung gramnegativer wirtzellen. | |
| DE59410401D1 (de) | VERFAHREN ZUR HERSTELLUNG REKOMBINANTER PilC-PROTEINE | |
| DE69031803D1 (de) | Verfahren und nukleinsäuresequenzen zur expression des zellulose-synthase-operons | |
| WO1998023750A3 (en) | Mammalian chemokines | |
| GB2171703B (en) | Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re | |
| DE59712554D1 (de) | Rekombinante expression von s-layer-proteinen | |
| CA2197075A1 (en) | Method of Gene Therapy Using DNA Vectors Without Selection Marker Gene | |
| ATE88499T1 (de) | Expressionsvektoren zur proteinsynthese sowie plasmidreplikons und sequenzkassetten, die zur herstellung solcher vektoren geeignet sind. | |
| WO1998027200A3 (en) | Human and mammalian dna replication origin consensus sequences | |
| DE3684405D1 (de) | Dna-fragment mit dem cyclodextrin-glycosyl-transferase-strukturgen, expressionsvektor, mikroorganismen zur expression und herstellungsverfahren. | |
| DE3882455D1 (de) | Verfahren zur herstellung von proteinen in loeslicher form. | |
| WO2002016578A3 (en) | Secreted proteins and methods of using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20091231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |